Dr. Theresa Mullin to Join CDER

September 13, 2007
BioPharm International Editors

Theresa Mullin, PhD, will join CDER on September 24, 2007, as the associate director for analysis and strategic initiatives.

Theresa Mullin, PhD, will join CDER on September 24, 2007, as the associate director for analysis and strategic initiatives. As associate director, she will lead CDER’s long-range planning and strategic modernization initiatives.

Mullin previously worked as the assistant commissioner for planning and as director of the office of planning in the office of the commissioner. As chief planner, she led the development of the FDA’s strategic action plans and performance plans that were incorporated into agency budget requests. Mullin played a role in establishing the FDA Bioinformatics Board and provided early support for the FDA critical path initiative. Prior to her work at the FDA, Mullin worked as a principal scientist with the Decision Science Consortium, and as senior manager with the Lewin Group.

Related Content:

News